医薬品製造受託機関の世界市場成長（現状と展望）2024-2030年

Global Pharmaceutical Contract Manufacture Organization Market Growth (Status and Outlook) 2024-2030

世界の医薬品製造受託機関市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は％と予測されています。 LPI（エルピーアイ情報）の最新調査レ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
LP Information LPインフォメーション	2024年5月24日	US$3,660 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	128	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の医薬品製造受託機関市場規模は、2023年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は％と予測されています。
LPI（エルピーアイ情報）の最新調査レポート「医薬品製造受託機関業界予測」は、2023年の医薬品製造受託機関の世界総売上高を過去の売上高と比較し、2024年から2030年までの医薬品製造受託機関の売上高予測を地域別・市場分野別に包括的に分析しています。医薬品製造受託機関の売上高を地域別、市場分野別、サブセクター別に分類し、世界の医薬品製造受託機関産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界の医薬品製造受託機関の状況を包括的に分析し、製品セグメンテーション、企業設立、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにしています。また本レポートでは、医薬品製造受託機関のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当て、世界の主要企業の戦略を分析し、加速する世界の医薬品製造受託機関市場におけるこれらの企業の独自の地位をより深く理解しています。
この調査レポートは、医薬品製造受託機関の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の医薬品製造受託機関の現状と将来の軌道について非常にニュアンスのある見解を提供します。
世界の医薬品市場は2022年に1,475億ドルに達し、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調しています。
本レポートでは、医薬品製造受託機関市場の包括的な概要、市場シェア、成長機会を、製品タイプ別、用途別、主要企業別、主要地域・国別に紹介する。
タイプ別セグメント
原薬（API）
完成用量製剤（FDFs）
用途別セグメント
専門/中堅
ジェネリック医薬品
大手製薬会社
その他
本レポートは地域別にも市場を分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ロンザ
ベーリンガーインゲルハイム
キャタレント
バクスター
アッヴィ
ファイザー
エボニック
ファレバグループ
アエノバ
アルマック
デルファーマ
レシファーム
アエシカ
ニプロ株式会社
大東薬品
テバAPI
エステベ・キミカ
ユーティカルズ
浙江ヒスン製薬

ページTOPに戻る

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Manufacture Organization Market Size 2019-2030
2.1.2 Pharmaceutical Contract Manufacture Organization Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmaceutical Contract Manufacture Organization Segment by Type
2.2.1 Active Pharmaceutical Ingredients (APIs)
2.2.2 Finished Dose Formulations (FDFs)
2.3 Pharmaceutical Contract Manufacture Organization Market Size by Type
2.3.1 Pharmaceutical Contract Manufacture Organization Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical Contract Manufacture Organization Market Size Market Share by Type (2019-2024)
2.4 Pharmaceutical Contract Manufacture Organization Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Others
2.5 Pharmaceutical Contract Manufacture Organization Market Size by Application
2.5.1 Pharmaceutical Contract Manufacture Organization Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical Contract Manufacture Organization Market Size Market Share by Application (2019-2024)
3 Pharmaceutical Contract Manufacture Organization Market Size by Player
3.1 Pharmaceutical Contract Manufacture Organization Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Manufacture Organization Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Manufacture Organization Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Manufacture Organization by Regions
4.1 Pharmaceutical Contract Manufacture Organization Market Size by Regions (2019-2024)
4.2 Americas Pharmaceutical Contract Manufacture Organization Market Size Growth (2019-2024)
4.3 APAC Pharmaceutical Contract Manufacture Organization Market Size Growth (2019-2024)
4.4 Europe Pharmaceutical Contract Manufacture Organization Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size Growth (2019-2024)
5 Americas
5.1 Americas Pharmaceutical Contract Manufacture Organization Market Size by Country (2019-2024)
5.2 Americas Pharmaceutical Contract Manufacture Organization Market Size by Type (2019-2024)
5.3 Americas Pharmaceutical Contract Manufacture Organization Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Contract Manufacture Organization Market Size by Region (2019-2024)
6.2 APAC Pharmaceutical Contract Manufacture Organization Market Size by Type (2019-2024)
6.3 APAC Pharmaceutical Contract Manufacture Organization Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Contract Manufacture Organization by Country (2019-2024)
7.2 Europe Pharmaceutical Contract Manufacture Organization Market Size by Type (2019-2024)
7.3 Europe Pharmaceutical Contract Manufacture Organization Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Manufacture Organization by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Contract Manufacture Organization Market Forecast
10.1 Global Pharmaceutical Contract Manufacture Organization Forecast by Regions (2025-2030)
10.1.1 Global Pharmaceutical Contract Manufacture Organization Forecast by Regions (2025-2030)
10.1.2 Americas Pharmaceutical Contract Manufacture Organization Forecast
10.1.3 APAC Pharmaceutical Contract Manufacture Organization Forecast
10.1.4 Europe Pharmaceutical Contract Manufacture Organization Forecast
10.1.5 Middle East & Africa Pharmaceutical Contract Manufacture Organization Forecast
10.2 Americas Pharmaceutical Contract Manufacture Organization Forecast by Country (2025-2030)
10.2.1 United States Pharmaceutical Contract Manufacture Organization Market Forecast
10.2.2 Canada Pharmaceutical Contract Manufacture Organization Market Forecast
10.2.3 Mexico Pharmaceutical Contract Manufacture Organization Market Forecast
10.2.4 Brazil Pharmaceutical Contract Manufacture Organization Market Forecast
10.3 APAC Pharmaceutical Contract Manufacture Organization Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical Contract Manufacture Organization Market Forecast
10.3.2 Japan Pharmaceutical Contract Manufacture Organization Market Forecast
10.3.3 Korea Pharmaceutical Contract Manufacture Organization Market Forecast
10.3.4 Southeast Asia Pharmaceutical Contract Manufacture Organization Market Forecast
10.3.5 India Pharmaceutical Contract Manufacture Organization Market Forecast
10.3.6 Australia Pharmaceutical Contract Manufacture Organization Market Forecast
10.4 Europe Pharmaceutical Contract Manufacture Organization Forecast by Country (2025-2030)
10.4.1 Germany Pharmaceutical Contract Manufacture Organization Market Forecast
10.4.2 France Pharmaceutical Contract Manufacture Organization Market Forecast
10.4.3 UK Pharmaceutical Contract Manufacture Organization Market Forecast
10.4.4 Italy Pharmaceutical Contract Manufacture Organization Market Forecast
10.4.5 Russia Pharmaceutical Contract Manufacture Organization Market Forecast
10.5 Middle East & Africa Pharmaceutical Contract Manufacture Organization Forecast by Region (2025-2030)
10.5.1 Egypt Pharmaceutical Contract Manufacture Organization Market Forecast
10.5.2 South Africa Pharmaceutical Contract Manufacture Organization Market Forecast
10.5.3 Israel Pharmaceutical Contract Manufacture Organization Market Forecast
10.5.4 Turkey Pharmaceutical Contract Manufacture Organization Market Forecast
10.5.5 GCC Countries Pharmaceutical Contract Manufacture Organization Market Forecast
10.6 Global Pharmaceutical Contract Manufacture Organization Forecast by Type (2025-2030)
10.7 Global Pharmaceutical Contract Manufacture Organization Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Pharmaceutical Contract Manufacture Organization Product Offered
11.1.3 Lonza Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Pharmaceutical Contract Manufacture Organization Product Offered
11.2.3 Boehringer Ingelheim Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Pharmaceutical Contract Manufacture Organization Product Offered
11.3.3 Catalent Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Baxter
11.4.1 Baxter Company Information
11.4.2 Baxter Pharmaceutical Contract Manufacture Organization Product Offered
11.4.3 Baxter Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Baxter Main Business Overview
11.4.5 Baxter Latest Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Pharmaceutical Contract Manufacture Organization Product Offered
11.5.3 AbbVie Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AbbVie Main Business Overview
11.5.5 AbbVie Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Pharmaceutical Contract Manufacture Organization Product Offered
11.6.3 Pfizer Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Evonik
11.7.1 Evonik Company Information
11.7.2 Evonik Pharmaceutical Contract Manufacture Organization Product Offered
11.7.3 Evonik Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Evonik Main Business Overview
11.7.5 Evonik Latest Developments
11.8 Fareva group
11.8.1 Fareva group Company Information
11.8.2 Fareva group Pharmaceutical Contract Manufacture Organization Product Offered
11.8.3 Fareva group Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fareva group Main Business Overview
11.8.5 Fareva group Latest Developments
11.9 Aenova
11.9.1 Aenova Company Information
11.9.2 Aenova Pharmaceutical Contract Manufacture Organization Product Offered
11.9.3 Aenova Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Aenova Main Business Overview
11.9.5 Aenova Latest Developments
11.10 Almac
11.10.1 Almac Company Information
11.10.2 Almac Pharmaceutical Contract Manufacture Organization Product Offered
11.10.3 Almac Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Almac Main Business Overview
11.10.5 Almac Latest Developments
11.11 Delpharm
11.11.1 Delpharm Company Information
11.11.2 Delpharm Pharmaceutical Contract Manufacture Organization Product Offered
11.11.3 Delpharm Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Delpharm Main Business Overview
11.11.5 Delpharm Latest Developments
11.12 Recipharm
11.12.1 Recipharm Company Information
11.12.2 Recipharm Pharmaceutical Contract Manufacture Organization Product Offered
11.12.3 Recipharm Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Recipharm Main Business Overview
11.12.5 Recipharm Latest Developments
11.13 Aesica
11.13.1 Aesica Company Information
11.13.2 Aesica Pharmaceutical Contract Manufacture Organization Product Offered
11.13.3 Aesica Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Aesica Main Business Overview
11.13.5 Aesica Latest Developments
11.14 NIPRO CORPORATION
11.14.1 NIPRO CORPORATION Company Information
11.14.2 NIPRO CORPORATION Pharmaceutical Contract Manufacture Organization Product Offered
11.14.3 NIPRO CORPORATION Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 NIPRO CORPORATION Main Business Overview
11.14.5 NIPRO CORPORATION Latest Developments
11.15 Daito Pharmaceutical
11.15.1 Daito Pharmaceutical Company Information
11.15.2 Daito Pharmaceutical Pharmaceutical Contract Manufacture Organization Product Offered
11.15.3 Daito Pharmaceutical Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Daito Pharmaceutical Main Business Overview
11.15.5 Daito Pharmaceutical Latest Developments
11.16 Teva API
11.16.1 Teva API Company Information
11.16.2 Teva API Pharmaceutical Contract Manufacture Organization Product Offered
11.16.3 Teva API Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Teva API Main Business Overview
11.16.5 Teva API Latest Developments
11.17 Esteve Quimica
11.17.1 Esteve Quimica Company Information
11.17.2 Esteve Quimica Pharmaceutical Contract Manufacture Organization Product Offered
11.17.3 Esteve Quimica Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Esteve Quimica Main Business Overview
11.17.5 Esteve Quimica Latest Developments
11.18 Euticals
11.18.1 Euticals Company Information
11.18.2 Euticals Pharmaceutical Contract Manufacture Organization Product Offered
11.18.3 Euticals Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Euticals Main Business Overview
11.18.5 Euticals Latest Developments
11.19 Zhejiang Hisun Pharmaceuticals
11.19.1 Zhejiang Hisun Pharmaceuticals Company Information
11.19.2 Zhejiang Hisun Pharmaceuticals Pharmaceutical Contract Manufacture Organization Product Offered
11.19.3 Zhejiang Hisun Pharmaceuticals Pharmaceutical Contract Manufacture Organization Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Zhejiang Hisun Pharmaceuticals Main Business Overview
11.19.5 Zhejiang Hisun Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

Table of Contents

Summary

The global Pharmaceutical Contract Manufacture Organization market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Pharmaceutical Contract Manufacture Organization Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Manufacture Organization sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Manufacture Organization sales for 2024 through 2030. With Pharmaceutical Contract Manufacture Organization sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Manufacture Organization industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Manufacture Organization landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Contract Manufacture Organization portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Manufacture Organization market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Manufacture Organization and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Manufacture Organization.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Manufacture Organization market by product type, application, key players and key regions and countries.
Segmentation by type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Segmentation by application
Specialty/Midsize
Generics
Big Pharma
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Boehringer Ingelheim
Catalent
Baxter
AbbVie
Pfizer
Evonik
Fareva group
Aenova
Almac
Delpharm
Recipharm
Aesica
NIPRO CORPORATION
Daito Pharmaceutical
Teva API
Esteve Quimica
Euticals
Zhejiang Hisun Pharmaceuticals

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

医薬品製造受託機関の世界市場成長（現状と展望）2024-2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?